Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,978 Psoriasis
clinical trials

Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
353
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
2018
mi
from 43215
Ventura, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
175
mi
from 43215
Warren, MI
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Neurology, Rheumatology Clinical Trial
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Rheumatology Consultants of Delaware dba Delaware Arthritis
428
mi
from 43215
Lewes, DE
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 53
99
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
322
mi
from 43215
High Point, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
412
mi
from 43215
Alpharetta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
998
mi
from 43215
Bellaire, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
405
mi
from 43215
Bethlehem, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
493
mi
from 43215
Macon, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
407
mi
from 43215
Newport News, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
652
mi
from 43215
Rogers, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
423
mi
from 43215
Sandy Springs, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
181
mi
from 43215
Troy, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
522
mi
from 43215
Trumbull, CT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
993
mi
from 43215
Webster, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
This Study is Being Conducted to Evaluate the Safety, Tolerability, and Efficacy of KD025 Administered Orally for 16 Weeks to Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy.
Status: Enrolling, Phase II
Updated: 3/6/2017
Metro Boston Clinical Partners
638
mi
from 43215
Brighton, MA
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Maintaining Lower Levels of Care Through Automated Perineal Hygiene
Status: Enrolling
Updated: 12/31/1969
The Village at Marymount
125
mi
from 43215
Garfield Heights, OH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Accurate Clinical Research, Inc. /ID# 160052
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Millennium Research /ID# 159833
746
mi
from 43215
Ormond Beach, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlantic Coast Research /ID# 159810
466
mi
from 43215
Toms River, NJ
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Aa Mrc Llc /Id# 159846
207
mi
from 43215
Grand Blanc, MI
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Rheumatology Consultants, PLLC /ID# 159796
282
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Colorado Arthritis Associates /ID# 159847
1167
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Dartmouth-Hitchcock Medical Center /ID# 161235
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Cape Fear Arthritis Care /ID# 161224
483
mi
from 43215
Leland, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
P&I Clinical Research /ID# 159826
887
mi
from 43215
Lufkin, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical Research /ID# 159894
1723
mi
from 43215
Meridian, ID
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Shores Rheumatology, PC /ID# 159889
175
mi
from 43215
Saint Clair Shores, MI
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Santa Fe Rheumatology /ID# 163783
1282
mi
from 43215
Santa Fe, NM
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
University of South Florida /ID# 161286
823
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Ocean Rheumatology, PA /ID# 163898
466
mi
from 43215
Toms River, NJ
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Deerbrook Medical Associates /ID# 159804
300
mi
from 43215
Vernon Hills, IL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Tekton Research, Inc. /ID# 160008
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
DJL Clinical Research, PLLC /ID# 161414
356
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
STAT Research, Inc. /ID# 161416
64
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Denver Arthritis Clinic, PC /ID# 159899
1157
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Arthritis Treatment Center /ID# 160053
300
mi
from 43215
Frederick, MD
Click here to add this to my saved trials
Psoriasis Clinical Trial
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling, Phase III
Updated: 12/31/1969
MetroBoston Clinical Partners
632
mi
from 43215
Needham, MA
Click here to add this to my saved trials
Psoriasis Clinical Trial
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling, Phase III
Updated: 12/31/1969
MediSearch Clinical Trials
624
mi
from 43215
Saint Joseph, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rady Children's Hospital - San Diego/University of California, San Diego
1948
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Dermatology Specialists of Spokane
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Apex Dermatology
1157
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
AboutSkin Dermatology and DermSurgery
1161
mi
from 43215
Greenwood Village, CO
Click here to add this to my saved trials
Psoriasis Clinical Trial
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
Status: Enrolling
Updated: 12/31/1969
Elise Nelson
448
mi
from 43215
East Windsor, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Kirk Barber Research
1670
mi
from 43215
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Dermatology & Laser Research
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah MidValley Dematology
1514
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
1670
mi
from 43215
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site 1
938
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
158
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
493
mi
from 43215
Macon, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
2099
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
633
mi
from 43215
Plymouth, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
1985
mi
from 43215
Rolling Hills Estates, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
2109
mi
from 43215
Santa Rosa, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermatologists of Greater Colombus
4
mi
from 43215
Bexley, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Revival Research
989
mi
from 43215
Doral, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovate Research, LLC
926
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
ActivMed Practices & Research, Inc.
668
mi
from 43215
Portsmouth, NH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 506
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 365
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 221
553
mi
from 43215
Bryant, AR
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 524
10
mi
from 43215
Dublin, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 525
337
mi
from 43215
Glenn Dale, MD
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 511
280
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 227
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Louisiana Dermatology Associates
800
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Wright State Univ School of Medicine
56
mi
from 43215
Fairborn, OH
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State Univ College Of Medicine
9
mi
from 43215
Gahanna, OH
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Owensboro Dermatology Associates
267
mi
from 43215
Owensboro, KY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Kirk Barber Research
1670
mi
from 43215
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Dermatology & Laser Research
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah MidValley Dematology
1514
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Bellaire Dermatology
997
mi
from 43215
Bellaire, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Bexley Dermatology Research
4
mi
from 43215
Bexley, OH
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
International Clinical Research
338
mi
from 43215
Murfreesboro, TN
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology and Skin Cancer Specialists
318
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
1 … 11 12 13 14 15 16 17 18 19 20